Related Experiment Video
Updated: Aug 17, 2026

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
Published on: October 6, 2015
Pharmacotherapy, vaccines and malaria advice for HIV-infected travellers
Matthias L Cavassini1, Valérie D'Acremont, Hansjakob Furrer
1Infectious Diseases Service, University Hospital, Lausanne, Switzerland.
Abstract:
Since the introduction of effective antiretroviral therapy (ART), HIV-infected individuals are travelling more frequently and international travel has become much safer. Specific concerns include the safety of ART during travel, drug adherence and interaction considerations, and effects of immunosuppression. This review describes potentially important infections, vaccine effectiveness, safety and special approaches for their use, and HIV-related issues regarding predeparture counselling. With advanced immunosuppression (CD4+ T-cell count < 200/microl or < 14%), the immunogenicity of several vaccines is reduced, complications could occur after live attenuated vaccines and certain infections acquired during travel may be more frequent or severe. Challenges include the best options for malaria chemoprophylaxis, standby treatment and medical follow-up of the increasing number of HIV-infected long-term travellers.
Related Concept Videos
Malaria
Cryptococcal Meningitis
Retrovirus Life Cycles
Yellow Fever
Sexually Transmitted Infections
Antiprotozoal Agents

